Review: Impact of COVID-19 pandemic on ST‐elevation myocardial infarction in a non‐COVID-19 epicenter

Review: Impact of COVID-19 pandemic on ST‐elevation myocardial infarction in a non‐COVID-19 epicenter

This study found that during the COVID-19 pandemic, patients presenting for ST-elevation myocardial infarction (STEMI) were more likely to present late and have lower left ventricle ejection fraction (LVEF) on presentation.  

  • From January 1, 2020, to April 15, 2020, 143 STEMIs were identified across our integrated 18‐hospital system.
  • The cut-off for pre‐ and post‐COVID‐19 cohorts was March 23rd, 2020, when stay‐at‐home orders were initiated in Ohio.
  • Compared with the pre‐COVID‐19 cohort, post‐COVID‐19 patients had a significantly lower initial LVEF (45 [34–50] vs. 50% [40–60], = .015)
  • 11/35 patients with STEMI in the post-COVID group presented > 12 hr after symptoms onset. Of these, 27% avoided the ED due to fear of COVID‐19, 18% believed symptoms were COVID‐19 related, and 9% did not want to burden the ED given the COVID‐19 pandemic
  • Among post‐COVID‐19 patients, those with >12‐hr delay in presentation had a longer average door-to-balloon time (88 vs. 53 min, = .033) and higher peak troponin (58 vs. 8.5 ng/ml, = .03)
|2020-06-04T09:36:59-04:00June 3rd, 2020|COVID-19 Literature|Comments Off on Review: Impact of COVID-19 pandemic on ST‐elevation myocardial infarction in a non‐COVID-19 epicenter

About the Author: CTSI Author

CTSI Author

Get Involved with Indiana CTSI